Pages that link to "Q34148663"
Jump to navigation
Jump to search
The following pages link to Review of the Literature and Proposed Guidelines for the Use of Oral Ribavirin as Postexposure Prophylaxis for Lassa Fever (Q34148663):
Displayed 50 items.
- Molecular diagnostics for lassa fever at Irrua specialist teaching hospital, Nigeria: lessons learnt from two years of laboratory operation (Q21092277) (← links)
- Lassa fever presenting as acute abdomen: a case series (Q21231955) (← links)
- Progress in the experimental therapy of severe arenaviral infections (Q27024953) (← links)
- Severe hemorrhagic fever in strain 13/N guinea pigs infected with Lujo virus (Q27305359) (← links)
- Effective oral favipiravir (T-705) therapy initiated after the onset of clinical disease in a model of arenavirus hemorrhagic Fever (Q28477434) (← links)
- Clinical features and patient management of Lujo hemorrhagic fever (Q28544917) (← links)
- Use of recombinant adenovirus vectored consensus IFN-α to avert severe arenavirus infection (Q28743512) (← links)
- Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin (Q30429521) (← links)
- Case-fatality ratio and effectiveness of ribavirin therapy among hospitalized patients in china who had severe fever with thrombocytopenia syndrome (Q33409920) (← links)
- In vitro antiviral activity of ribavirin against severe fever with thrombocytopenia syndrome virus (Q33437185) (← links)
- Coronaviruses - drug discovery and therapeutic options. (Q34513643) (← links)
- Lassa fever - full recovery without ribavarin treatment: a case report (Q35207231) (← links)
- Genomic profiling of host responses to Lassa virus: therapeutic potential from primate to man (Q35248863) (← links)
- Replication of boid inclusion body disease-associated arenaviruses is temperature sensitive in both boid and mammalian cells (Q35402001) (← links)
- Viruses acquired abroad: what does the primary care physician need to know? (Q36365735) (← links)
- A recently isolated Lassa virus from Mali demonstrates atypical clinical disease manifestations and decreased virulence in cynomolgus macaques (Q36702610) (← links)
- Healthcare-associated Crimean-Congo haemorrhagic fever in Turkey, 2002-2014: a multicentre retrospective cross-sectional study (Q37256780) (← links)
- Rodent-borne hemorrhagic fevers: under-recognized, widely spread and preventable - epidemiology, diagnostics and treatment (Q38016471) (← links)
- Ribavirin inhibits Zika virus (ZIKV) replication in vitro and suppresses viremia in ZIKV-infected STAT1-deficient mice (Q38156701) (← links)
- Ebola and other viral haemorrhagic fevers: a local operational approach (Q38248666) (← links)
- Residues K465 and G467 within the Cytoplasmic Domain of GP2 Play a Critical Role in the Persistence of Lymphocytic Choriomeningitis Virus in Mice (Q38736159) (← links)
- General Molecular Strategy for Development of Arenavirus Live-Attenuated Vaccines (Q39097131) (← links)
- Transcription and replication mechanisms of Bunyaviridae and Arenaviridae L proteins (Q39110012) (← links)
- Postexposure prophylaxis for Lassa fever: Experience from a recent outbreak in Nigeria (Q39388305) (← links)
- Efficient rescue of recombinant Lassa virus reveals the influence of S segment noncoding regions on virus replication and virulence (Q39595245) (← links)
- The High Degree of Sequence Plasticity of the Arenavirus Noncoding Intergenic Region (IGR) Enables the Use of a Nonviral Universal Synthetic IGR To Attenuate Arenaviruses (Q39602870) (← links)
- Resistance of human plasmacytoid dendritic CAL-1 cells to infection with lymphocytic choriomeningitis virus (LCMV) is caused by restricted virus cell entry, which is overcome by contact of CAL-1 cells with LCMV-infected cells (Q40069302) (← links)
- Treatment of Lassa virus infection in outbred guinea pigs with first-in-class human monoclonal antibodies (Q40092356) (← links)
- Emerging infectious diseases: Focus on infection control issues for novel coronaviruses (Severe Acute Respiratory Syndrome-CoV and Middle East Respiratory Syndrome-CoV), hemorrhagic fever viruses (Lassa and Ebola), and highly pathogenic avian influe (Q40107887) (← links)
- Lessons learnt from the management of a case of Lassa fever and follow-up of nosocomial primary contacts in Nigeria during Ebola virus disease outbreak in West Africa (Q40147436) (← links)
- Arenavirus Genome Rearrangement for the Development of Live Attenuated Vaccines (Q40156113) (← links)
- Severity scoring index for Crimean-Congo hemorrhagic fever and the impact of ribavirin and corticosteroids on fatality (Q40237945) (← links)
- Arenavirus and West Nile virus in solid organ transplantation. (Q40255394) (← links)
- Management of a Lassa fever outbreak, Rhineland-Palatinate, Germany, 2016. (Q41919414) (← links)
- Metabolomics analyses identify platelet activating factors and heme breakdown products as Lassa fever biomarkers (Q41929865) (← links)
- Risk factors associated with fatality of severe fever with thrombocytopenia syndrome: a meta-analysis (Q46251489) (← links)
- A DNA vaccine delivered by dermal electroporation fully protects cynomolgus macaques against Lassa fever (Q46768300) (← links)
- Movement Patterns of Small Rodents in Lassa Fever-Endemic Villages in Guinea. (Q51145289) (← links)
- Lassa fever: another threat from West Africa. (Q51333133) (← links)
- Field validation of recombinant antigen immunoassays for diagnosis of Lassa fever. (Q52590886) (← links)
- Baseline mapping of Lassa fever virology, epidemiology and vaccine research and development. (Q52723914) (← links)
- Re-emerging Lassa fever outbreaks in Nigeria: Re-enforcing "One Health" community surveillance and emergency response practice. (Q55188128) (← links)
- Systematic Review and Meta-analysis of Postexposure Prophylaxis for Crimean-Congo Hemorrhagic Fever Virus among Healthcare Workers (Q56395333) (← links)
- Current research for a vaccine against Lassa hemorrhagic fever virus (Q56909960) (← links)
- A Case of Lassa Fever Diagnosed at a Community Hospital-Minnesota 2014 (Q57002447) (← links)
- Genomic Analysis of Lassa Virus during an Increase in Cases in Nigeria in 2018 (Q57454077) (← links)
- Inosine Triphosphate Pyrophosphatase Dephosphorylates Ribavirin Triphosphate and Reduced Enzymatic Activity Potentiates Mutagenesis in Hepatitis C Virus (Q58682726) (← links)
- Use of Favipiravir to Treat Lassa Virus Infection in Macaques (Q58777764) (← links)
- Case Report: Imported Case of Lassa Fever - New Jersey, May 2015 (Q59355637) (← links)
- Diagnostic applications for Lassa fever in limited-resource settings (Q64246749) (← links)